224 related articles for article (PubMed ID: 37919768)
1. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
[TBL] [Abstract][Full Text] [Related]
2. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning.
Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D
Front Genet; 2023; 14():1193944. PubMed ID: 37456667
[No Abstract] [Full Text] [Related]
3. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
[TBL] [Abstract][Full Text] [Related]
4. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Yang L; Zhang W; Yan Y
Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
[TBL] [Abstract][Full Text] [Related]
7. Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma.
Li XM; Liu SP; Li Y; Cai XM; Zhang SB; Xie ZF
Heliyon; 2023 Aug; 9(8):e18436. PubMed ID: 37520990
[TBL] [Abstract][Full Text] [Related]
8. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing.
Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J
Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866
[No Abstract] [Full Text] [Related]
10. Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
Yan J; Fang Z; Shi M; Tu C; Zhang S; Jiang C; Li Q; Shao Y
J Cancer; 2024; 15(4):1053-1066. PubMed ID: 38230212
[No Abstract] [Full Text] [Related]
11. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
[TBL] [Abstract][Full Text] [Related]
12. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
Jin T; Yin T; Xu R; Liu H; Yuan S; Xue Y; Zhang J; Wang H
Transl Oncol; 2024 Jun; 44():101938. PubMed ID: 38492499
[TBL] [Abstract][Full Text] [Related]
14. A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma.
Zhang HB; Pan JY; Zhu T
Front Pharmacol; 2023; 14():1254119. PubMed ID: 37822882
[No Abstract] [Full Text] [Related]
15. Development and experimental verification of a prognosis model for disulfidptosis-associated genes in HNSCC.
Li Y; Tao L; Xin J; Dai Y; Chen X; Zou J; Wang R; Wang B; Liu Z
Medicine (Baltimore); 2024 Mar; 103(12):e37308. PubMed ID: 38518012
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
17. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38836761
[TBL] [Abstract][Full Text] [Related]
18. Hub gene of disulfidptosis-related immune checkpoints in breast cancer.
Wang Y; Deng Y; Xie H; Cao S
Med Oncol; 2023 Jul; 40(8):222. PubMed ID: 37402987
[TBL] [Abstract][Full Text] [Related]
19. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.
Cong Y; Cai G; Ding C; Zhang H; Chen J; Luo S; Liu J
Front Genet; 2024; 15():1378907. PubMed ID: 38694875
[TBL] [Abstract][Full Text] [Related]
20. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
Chen X; Liang Q; Zhou Y
Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]